Generic Name : Belladonna Alkaloid Combinations and Phenobarbital
TradeName : Belladenal, Donnatal
Why it is prescribed (Indications) :
1. This combination of drugs is used to relieve cramping pains in the digestive tract to treat ulcers.
2. It decreases the motion of the stomach and intestines and the secretion of acid.
When it is to be taken : This medication is usually taken three or four times a day, 30 minutes before meals and at bedtime.
How it should be taken : This medication comes in the form of tablets and liquid.Your prescription label tells you how much to take at each dose.
Special Instruction :
1. This medication makes some people drowsy. Do not drive a car or operate dangerous machinery until you know how it affects you.
2. Belladonna alkaloids may decrease sweating and cause heatstroke. Be careful of overheating during exercise and in hot weather.
3. Antacids may decrease the effectiveness of this medication and hence do not take antacids within one hour of taking it.
Side Effects :
Dry mouth or throat,increased eye sensitivity to light,confusion,eye pain, skin rash, constipation, blurred vision, dizziness, nervousness, rapid heartbeat, skin flushing and difficulty urinating are seen. These symptoms usually go away as your body adjusts to the medication. If they persist or severe, contact your doctor.
Other Precautions :
1. If you ever had an unusual reaction to belladonna or to any barbiturate, tell your doctor before taking this medication.
2. This medication should not be taken by patients with kidney or liver disease, glaucoma, or certain diseases of the urinary tract or heart. If you have any of these diseases, inform your doctor before you begin this drug.
3. Let your doctor know if you are pregnant or breast-feeding.
4. Tell your doctor regarding your prescription and nonprescription medications.
5. Alcoholic beverages may add to the drowsiness caused by this drug.
Storage Conditions :
Keep this medication in the container it came in, out of direct sunlight, and out of the reach of children.
No comments:
Post a Comment